Transjugular melody valve placement in a small child with protein losing enteropathy

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 2, 2015, Pages 267-270

  Mallula, Kiran K ^a   Kenny, Damien ^a   Hijazi, Ziyad M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Melody valve; Percutaneous; Protein losing enteropathy; Transcatheter

Indexed keywords

ALPHA 1 ANTITRYPSIN; BUDESONIDE; DIURETIC AGENT; IMMUNOGLOBULIN G;

ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ATRIOVENTRICULAR SEPTAL DEFECT; CARDIOVASCULAR STENT; CASE REPORT; CHILD; DEXTROCARDIA; DISEASE EXACERBATION; FALLOT TETRALOGY; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VALVE REPLACEMENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERNAL JUGULAR VEIN; LUNG INSUFFICIENCY; MALE; PRESCHOOL CHILD; PROTEIN DIET; PROTEIN LOSING GASTROENTEROPATHY; SITUS INVERSUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSJUGULAR MELODY VALVE PLACEMENT; VASCULAR ACCESS;

EID: 84964253131     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25487     Document Type: Article

References (8)

1. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol 2009;54:1722-1729.
2. McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, Vincent JA. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507-516.
3. Simpson KE, Huddleston CB, Foerster S, Nicholas R, Balzer D. Successful subxyphoid hybrid approach for placement of a Melody percutaneous pulmonary valve. Catheter Cardiovasc Interv 2011;78:108-111.
4. Yamanaka O, Ozaki H, Kanoh T, Wada T, Satoh H, Yamaguchi H. [A case of isolated tricuspid regurgitation associated with protein-losing gastroenteropathy]. Kokyu To Junkan 1989;37:351-356.
5. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, Hellenbrand WE. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv 2011;4:602-614.
6. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2007;2:288-300.
7. Cheung YF, Tsang HY, Kwok JS. Immunologic profile of patients with protein-losing enteropathy complicating congenital heart disease. Pediatr Cardiol 2002;23:587-593.
8. Straver B, Wagenaar LJ, Blom NA, Mulder BJ, Bouma BJ, Hazekamp MG, de Winter RJ. Percutaneous tricuspid valve implantation in a Fontan patient with congestive heart failure and protein-losing enteropathy. Circ Cardiovasc Interv 2011;4:112-113.